The Standard of Care for Evaluating Metastatic Risk in Your Newly Diagnosed Uveal Melanoma Patients
The Standard of Care for Evaluating Metastatic Risk in Your Newly Diagnosed Uveal Melanoma Patients
DecisionDx®-UM Overview
Genomic testing with DecisionDx-UM enables accurate assessment of metastatic risk.
Clinical Validation
DecisionDx-UM is extensively researched including multiple prospective studies.
Test Process
Learn more about the straightforward ordering process for DecisionDx-UM.
Scientific References
DecisionDx-UM is supported by 19 peer-reviewed publications.
Resources
A broad range of resources are available to support the use of DecisionDx-UM.
Additional Uveal Melanoma Tests
Additional DecisionDx tests designed to improve the treatment and management of uveal melanoma.
This site uses cookies to offer you a better browsing experience. Read our Privacy Policy.
We use cookies and share data with services that improve your experience on this site. Read our <a href="/privacy-policy/">Privacy Policy</a>.<br />
Opt-Out
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
